12-Aug-2021 - Forschungszentrum Jülich GmbH

Alzheimer’s Research: New Insights into the Formation of Toxic Protein Clumps

In slightly acidic conditions Aβ oligomers form around 8,000 times quicker than for a neutral pH

Small aggregates of proteins known as Aβ oligomers are suspected as the main cause for the development of Alzheimer’s disease. However, it is not yet clear where and under what conditions these toxic aggregates form. Researchers from Heinrich Heine University Düsseldorf and Forschungszentrum Jülich, together with partners from the University and University Hospital Cologne, have now found that a slightly acidic milieu is conducive to this development. In this environment, the oligomers form around 8,000 times quicker than for a neutral pH, as the scientists write in the journal Nature Communications. Such a slightly decreased pH also can be found in certain substructures of nerve cells.

The precise causes of Alzheimer's disease are yet to be fully understood despite intensive research. For decades, there was a focus on characteristic protein deposits in the brains of Alzheimer’s patients that can be clearly seen with a microscope. Today, researchers instead concentrate on the “smaller relatives” of these deposits, oligomers. These are also accumulations of the amyloid-beta (Aβ) peptide, but on a much smaller scale typically comprising just a few units.

Aβ is not harmful in itself and can also be found in healthy individuals. It tends to assemble into toxic structures when, for instance, metabolic processes are disrupted in the brain. The biochemical processes that trigger these toxic oligomers are seen as the cause of Alzheimer's disease. However, it is unclear where and how these oligomers form. In vitro, it has not yet been possible to replicate the process under realistic conditions. The amounts of Aβ required to do so are considerably higher than those that can be detected in the brain fluid.

In the study that has now been published, the researchers were able to show that the development of the oligomers is very highly dependent on the pH value. In slightly acidic conditions, they form 8,000 times quicker than for a neutral pH value. Such conditions can be found, for instance, in certain substructures of cells known as endosomes and lysosomes – small bubbles or vesicles that play a central role in the transport and degradation of substances in the cell.

“The amounts of Aβ found in these cell regions are thus sufficient to enable the formation of Aβ oligomers,” explains Wolfgang Hoyer from Heinrich Heine University Düsseldorf and Forschungszentrum Jülich.

Endosomes and lysosomes have long been a focal point of Alzheimer’s research. These are the sites where individual Aβ molecules develop in the first place through the breakdown of a precursor protein. They are also assembly points to which Aβ absorbed from the cell is transported. “Our results now indicate that endosomes and lysosomes are also the sites at which Aβ oligomers are preferentially formed,” Hoyer explains.

Study provides explanations for the maldistribution of protein

The researchers were also able to establish a link between the toxic Aβ oligomers and another feature of Alzheimer’s disease. After adding the Aβ oligomers, they observed an erroneous distribution of the tau protein within the nerve cells. The tau protein is a second protein that is closely linked with the progress of Alzheimer’s disease. Its occurrence in the wrong locations can lead to disruptions to the activity and structure of the nerve cells.

“The maldistribution and other pathological changes of the tau protein are critical to the loss of function of the nerve cells and the cognitive impairments of Alzheimer’s patients. The fact that the Aβ oligomers described here can trigger this pathological change of the tau protein in nerve cells underlines the high pathophysiological relevance of the study,” explains Hans Zempel from University Hospital Cologne.

The team of researchers was also able to investigate the size and form of the oligomers by means of cryo-electron microscopy and atomic force microscopy. “The findings obtained provide a basis to gain a better understanding of the special properties and impact of these critical protein aggregates,” Hoyer says. This will help with the development of diagnosis and treatment strategies that specifically target oligomers.

Facts, background information, dossiers

  • protein aggregates
  • proteins
  • oligomers
  • Alzheimer's disease
  • amyloid beta

More about Forschungszentrum Jülich

  • News

    A New Tool for Cryo-Electron Microscopy

    Researchers at Forschungszentrum Jülich and Heinrich Heine University Düsseldorf led by Prof. Dr. Carsten Sachse are using cryo-electron microscopy, or cryo-EM for short, to make biomolecules visible at the atomic level. In a paper now published in the journal Nature Methods, they present a ... more

    Synapses as a model: solid-state memory in neuromorphic circuits

    They are many times faster than flash memory and require significantly less energy: memristive memory cells could revolutionize the energy efficiency of neuromorphic computers. In these computers, which are modeled on the way the human brain works, memristive cells function like artificial ... more

    Increasing the Activity of Catalysts

    A layer as thin as a single atom makes a huge difference: On the surface of an electrode, it doubles the amount of water split in an electrolysis system without increasing the energy requirements. Thus, the ultrathin layer also doubles the amount of hydrogen produced without increasing cost ... more

  • q&more articles

    Macromolecular environments influence proteins

    The high-intensity interaction of proteins with other macromolecules can cause signifi cant changes to protein properties such as translational mobility, for example, or their conformational states. Accordingly, the study of proteins in macromolecular environments that typically very closel ... more

    Caffeine Kick

    Caffeine is the most widely consumed psychoactive substance worldwide. It supplies the active ingredient in beverages such as coffee, tea and energy drinks. Caffeine can focus vigilance and attention, reduce drowsiness and enhance the ability to perform cognitive functions. Its neurobiologi ... more

  • Authors

    Prof. Dr. Jörg Fitter

    Jörg Fitter studied physics at the University of Hamburg. After completing his doctoral studies at FU Berlin, he worked in neutron scattering and molecular biophysics at the Hahn Meitner Institute in Berlin and Jülich Research Center. He completed his habilitation in physical biology at Hei ... more

    Dr. David Elmenhorst

    studied medicine in Aachen before receiving his doctorate in sleep research from the German Aerospace Centre (Deutsches Zentrum für Luft- und Raumfahrt, DLR) in Cologne. During 2008/2009, he was a visiting researcher at the Brain Imaging Centre in Canada’s Montreal Neurological Institute an ... more

    Prof. Dr. Andreas Bauer

    studied medicine and philosophy in Aachen, Cologne and Düsseldorf, where he received his doctorate in the field of neuroreceptor autoradiography. After specialist medical training at Cologne University Hospital he completed his habilitation in neurology at the University of Düsseldorf. Sinc ... more

q&more – the networking platform for quality excellence in lab and process

The q&more concept is to increase the visibility of recent research and innovative solutions, and support the exchange of knowledge. In the broad spectrum of subjects covered, the focus is on achieving maximum quality in highly innovative sectors. As a modern knowledge platform, q&more offers market participants one-of-a-kind networking opportunities. Cutting-edge research is presented by authors of international repute. Attractively presented in a high-quality context, and published in German and English, the original articles introduce new concepts and highlight unconventional solution strategies.

> more about q&more

q&more is supported by: